Immunotherapy and Cell Based Strategies in Brain Cancer By 2026, the arsenal of neuro-oncology treatment options has expanded to include sophisticated immunotherapy platforms, such as CAR-T cell therapy specifically engineered to cross the blood-brain barrier. These treatments represent a major leap in precision medicine glioma, as they utilize the patient's own immune system to identify and...